Vaxxinity Stock Performance
| VAXX Stock | USD 0.0001 0.02 99.42% |
Vaxxinity holds a performance score of 25 on a scale of zero to a hundred. The entity has a beta of 95.0, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vaxxinity will likely underperform. Use Vaxxinity maximum drawdown, skewness, as well as the relationship between the Skewness and period momentum indicator , to analyze future returns on Vaxxinity.
Risk-Adjusted Performance
Solid
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Vaxxinity are ranked lower than 25 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Vaxxinity showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Vaxxinity |
Vaxxinity Relative Risk vs. Return Landscape
If you would invest 0.01 in Vaxxinity on November 17, 2025 and sell it today you would earn a total of 0.00 from holding Vaxxinity or generate 0.0% return on investment over 90 days. Vaxxinity is currently generating 104.5372% in daily expected returns and assumes 324.4651% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Vaxxinity, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Vaxxinity Target Price Odds to finish over Current Price
The tendency of Vaxxinity Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.0001 | 90 days | 0.0001 | about 71.35 |
Based on a normal probability distribution, the odds of Vaxxinity to move above the current price in 90 days from now is about 71.35 (This Vaxxinity probability density function shows the probability of Vaxxinity Pink Sheet to fall within a particular range of prices over 90 days) .
Vaxxinity Price Density |
| Price |
Predictive Modules for Vaxxinity
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Vaxxinity. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vaxxinity's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vaxxinity Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Vaxxinity is not an exception. The market had few large corrections towards the Vaxxinity's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Vaxxinity, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Vaxxinity within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1,016 | |
β | Beta against Dow Jones | 95.00 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.27 |
Vaxxinity Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vaxxinity for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vaxxinity can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Vaxxinity is way too risky over 90 days horizon | |
| Vaxxinity has some characteristics of a very speculative penny stock | |
| Vaxxinity appears to be risky and price may revert if volatility continues | |
| Vaxxinity has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (56.93 M) with loss before overhead, payroll, taxes, and interest of (1.87 M). | |
| Vaxxinity currently holds about 128.23 M in cash with (57.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 51.0% of the company outstanding shares are owned by insiders |
Vaxxinity Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vaxxinity Pink Sheet often depends not only on the future outlook of the current and potential Vaxxinity's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vaxxinity's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 126.5 M | |
| Cash And Short Term Investments | 30.5 M |
Vaxxinity Fundamentals Growth
Vaxxinity Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Vaxxinity, and Vaxxinity fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vaxxinity Pink Sheet performance.
| Return On Equity | -1.51 | |||
| Return On Asset | -0.48 | |||
| Current Valuation | (1.39 M) | |||
| Shares Outstanding | 112.91 M | |||
| Price To Book | 4.58 X | |||
| Price To Sales | 4,605 X | |||
| EBITDA | (56.05 M) | |||
| Cash And Equivalents | 128.23 M | |||
| Cash Per Share | 1.02 X | |||
| Total Debt | 15.17 M | |||
| Debt To Equity | 0.09 % | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (57.24 M) | |||
| Earnings Per Share | (0.45) X | |||
| Total Asset | 44.35 M | |||
| Retained Earnings | (361.64 M) | |||
About Vaxxinity Performance
Evaluating Vaxxinity's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Vaxxinity has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Vaxxinity has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas. Vaxxinity Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 89 people.Things to note about Vaxxinity performance evaluation
Checking the ongoing alerts about Vaxxinity for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Vaxxinity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Vaxxinity is way too risky over 90 days horizon | |
| Vaxxinity has some characteristics of a very speculative penny stock | |
| Vaxxinity appears to be risky and price may revert if volatility continues | |
| Vaxxinity has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (56.93 M) with loss before overhead, payroll, taxes, and interest of (1.87 M). | |
| Vaxxinity currently holds about 128.23 M in cash with (57.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 51.0% of the company outstanding shares are owned by insiders |
- Analyzing Vaxxinity's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vaxxinity's stock is overvalued or undervalued compared to its peers.
- Examining Vaxxinity's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Vaxxinity's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vaxxinity's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Vaxxinity's pink sheet. These opinions can provide insight into Vaxxinity's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Vaxxinity Pink Sheet Analysis
When running Vaxxinity's price analysis, check to measure Vaxxinity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxxinity is operating at the current time. Most of Vaxxinity's value examination focuses on studying past and present price action to predict the probability of Vaxxinity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxxinity's price. Additionally, you may evaluate how the addition of Vaxxinity to your portfolios can decrease your overall portfolio volatility.